Summit Therapeutics plc (SMMT) News

Summit Therapeutics plc (SMMT): $3.38

0.94 (-21.76%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add SMMT to Watchlist
Sign Up

Filter SMMT News Items

SMMT News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest SMMT News From Around the Web

Below are the latest news stories about SUMMIT THERAPEUTICS INC that investors may wish to consider to help them evaluate SMMT as an investment opportunity.

Insiders hold 82% of Summit Therapeutics Inc. (NASDAQ:SMMT), and they've been buying recently

Key Insights Insiders appear to have a vested interest in Summit Therapeutics' growth, as seen by their sizeable...

Yahoo | November 27, 2023

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call. All participants will be able to listen only until the question-and-answer portion of this call. We do not expect any technical difficulties today; however, in the event […]

Yahoo | November 8, 2023

Summit Therapeutics Inc (SMMT) Reports Q3 Financial Results and Operational Progress

Company's net loss for the nine months ended September 30, 2023, stands at $578.4 million, largely due to in-process research and development expenses

Yahoo | November 7, 2023

Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023

MENLO PARK, Calif., November 07, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the third quarter and nine months ended September 30, 2023.

Yahoo | November 7, 2023

Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development

MENLO PARK, Calif., November 02, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Laura Chow, MD, has joined Summit Therapeutics as Senior Vice President of Clinical Development.

Yahoo | November 2, 2023

Ivonescimab’s Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023

MENLO PARK, Calif., October 31, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in San Diego, CA. The poster with updated data describing ivonescimab’s mechanism of action will be displayed on Saturday November 4, 2023, from 11:55am to 1:25pm Pacific Time.

Yahoo | October 31, 2023

Summit Therapeutics to Host Q3 2023 Financial Results & Operational Progress Call on November 7, 2023

MENLO PARK, Calif., October 26, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") will host an earnings call to announce its third quarter 2023 financial results and provide an operational update for the Company on Tuesday, November 7, 2023, before the market opens.

Yahoo | October 26, 2023

H. Jack West, MD, Renowned Oncologist & Lung Cancer Expert, Joins Summit Therapeutics as Vice President of Clinical Development

MENLO PARK, Calif., October 19, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Howard "Jack" West, MD, has joined Summit Therapeutics as Vice President of Clinical Development focused on lung cancer.

Yahoo | October 19, 2023

Insider Buying: COO Manmeet Soni Acquires 2,976,190 Shares of Summit Therapeutics Inc

In a significant move, Manmeet Soni, the Chief Operating Officer (COO) of Summit Therapeutics Inc (NASDAQ:SMMT), purchased 2,976,190 shares of the company on October 13, 2023.

Yahoo | October 17, 2023

Summit Therapeutics Appoints Proven Biotech Leader Manmeet S. Soni as Chief Operating Officer

MENLO PARK, Calif., October 16, 2023--Manmeet Soni joins Summit as Chief Operating Officer. Dave Gancarz, Urte Gayko, Fong Clow, and Allen Yang have been elevated to new leadership roles.

Yahoo | October 16, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!